Liberty Biopharma (CVE:LTY) Share Price Crosses Below Two Hundred Day Moving Average – What’s Next?

Liberty Biopharma Inc (CVE:LTY)’s stock price crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of C$2.00 and traded as low as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares changing hands.

Liberty Biopharma Price Performance

The company has a quick ratio of 0.12, a current ratio of 0.12 and a debt-to-equity ratio of 8.19. The firm has a fifty day moving average price of C$2.00 and a two-hundred day moving average price of C$2.00. The stock has a market capitalization of C$21.54 million and a P/E ratio of -12.66.

Liberty Biopharma Company Profile

Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.